Plasma proteomic alterations in non-human primates and humans after chronic alcohol self-administration

International Journal of Neuropsychopharmacology

Volumn 14, Issue 7, 2011, Pages 899-911

  Freeman, Willard M ^a   Vanguilder, Heather D ^a   Guidone, Elizabeth ^c   Krystal, John H ^c,d   Grant, Kathleen A ^b   Vrana, Kent E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Alcohol abuse; alcoholism; biomarker; diagnostic; plasma; proteomic

Indexed keywords

ALCOHOL; CLUSTERIN; FIBRONECTIN; INTER ALPHA INHIBITOR H4; PLASMA PROTEIN; RETINOL BINDING PROTEIN; SERUM AMYLOID A; SERUM AMYLOID A4; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOBLOTTING; LONG TERM EXPOSURE; MACACA FASCICULARIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; ALCOHOLISM; ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ETHANOL; HUMANS; MACACA FASCICULARIS; MALE; PRIMATES; PROTEOMICS; SELF ADMINISTRATION;

EID: 80052967122     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000046     Document Type: Article

References (58)

1. Akira S, Hirano T, Taga T, Kishimoto T (1990). Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB Journal 4, 2860-2867. (Pubitemid 120012532)
2. Alte D, Ludemann J, Piek M, Adam C, et al. (2003). Distribution and dose response of laboratory markers to alcohol consumption in a general population: results of the study of health in Pomerania (SHIP). Journal of Studies on Alcohol and Drugs 64, 75-82. (Pubitemid 36194061)
3. Anderson NL, Anderson NG (2002). The human plasma proteome: history, character, and diagnostic prospects. Molecular & Cellular Proteomics 1, 845-867.
4. Anton RF, Lieber C, Tabakoff B (2002). Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcoholism: Clinical and Experimental Research 26, 1215-1222. (Pubitemid 34913207)
5. APA (2000). Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. Washington, D.C.: American Psychiatric Association.
6. Bausserman LL, Herbert PN, McAdam KP (1980). Heterogeneity of human serum amyloid A proteins. Journal of Experimental Medicine 152, 641-656. (Pubitemid 10059495)
7. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, et al. (2007). AUDIT-C as a brief screen for alcohol misuse in primary care. Alcoholism: Clinical and Experimental Research 31, 1208-1217. (Pubitemid 46934387)
8. Brener ND, Billy JO, Grady WR (2003). Assessment of factors affecting the validity of self-reported health-risk behaviour among adolescents: evidence from the scientific literature. Journal of Adolescent Health 33, 436-457. (Pubitemid 37474078)
9. Burnham EL, Moss M, Ritzenthaler JD, Roman J (2007). Increased fibronectin expression in lung in the setting of chronic alcohol abuse. Alcoholism: Clinical and Experimental Research 31, 675-683. (Pubitemid 46434904)
10. Bush K, Kivlahan DR, McDonell MB, Fihn SD, et al. (1998). The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of Internal Medicine 158, 1789-1795. (Pubitemid 28421422)
11. Conigrave KM, Davies P, Haber P, Whitfield JB (2003). Traditional markers of excessive alcohol use. Addiction 98 (Suppl. 2), 31-43. (Pubitemid 38030760)
12. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, et al. (2002). CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcoholism : Clinical and Experimental Research 26, 332-339. (Pubitemid 34225837)
13. Crews FT, Bechara R, Brown LA, Guidot DM, et al. (2006). Cytokines and alcohol. Alcoholism: Clinical and Experimental Research 30, 720-730.
14. Das SK, Dhanya L, Vasudevan DM (2008). Biomarkers of alcoholism: an updated review. Scandinavian Journal of Clinical & Laboratory Investigation 68, 81-92. (Pubitemid 351481734)
15. Dhalla S, Kopec JA (2007). The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clinical and Investigative Medicine 30, 33-41. (Pubitemid 47457398)
16. Ewing JA (1984). Detecting alcoholism. The CAGE questionnaire. Journal of the American Medical Association 252, 1905-1907. (Pubitemid 14002155)
17. Falk D (1961). Production of polydipsia in normal rats by an intermittent food schedule. Science 133, 195-196.
18. First M, Spitzer RL, Gibbon M, Williams JBW (2010). Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I/NP). New York: Biometrics Research Department, New York State Psychiatric Institute.
19. Frank D, DeBenedetti AF, Volk RJ, Williams EC, et al. (2008). Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic groups. Journal of General Internal Medicine 23, 781-787.
20. Freeman WM, Gooch RS, Lull ME, Worst TJ, et al. (2006a). Apo-aii is an elevated biomarker of chronic non-human primate ethanol self-administration. Alcohol and Alcoholism 41, 300-305.
21. Freeman WM, Lull ME, Guilford MT, Vrana KE (2006b). Depletion of abundant proteins from non-human primate serum for biomarker studies. Proteomics 6, 3109-3113. (Pubitemid 43806408)
22. Freeman WM, Salzberg AC, Gonzales SW, Grant KA, et al. (2010). Classification of alcohol abuse by plasma protein biomarkers. Biological Psychiatry 68, 219-222.
23. Freeman WM, Vrana KE (2010). Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders. Alcoholism: Clinical and Experimental Research 34, 946-954.
24. Ghosh P, Hale EA, Lakshman MR (2001). Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker. Alcohol 25, 173-179. (Pubitemid 34143114)
25. Golka K, Wiese A (2004). Carbohydrate-deficient transferrin (CDT)-a biomarker for long-term alcohol consumption. Journal of Toxicology and Environmental Health Part B: Critical Reviews 7, 319-337. (Pubitemid 38789290)
26. Grant KA, Bennett AJ (2003). Advances in nonhuman primate alcohol abuse and alcoholism research. Pharmacology & Therapeutics 100, 235-255. (Pubitemid 37494908)
27. Grant KA, Leng X, Green HL, Szeliga KT, et al. (2008a). Drinking typography established by scheduled induction predicts chronic heavy drinking in a monkey model of ethanol self-administration. Alcoholism: Clinical and Experimental Research 32, 1824-1838.
28. Grant KA, Stafford J, Thiede A, Kiley C, et al. (2008b). Who's at risk? Population characterization of alcohol self-administration in nonhuman primates helps identify pathways to dependence. Alcohol Research and Health 34, 289-297.
29. Green KL, Szeliga KT, Bowen CA, Kautz MA, et al. (1999). Comparison of ethanol metabolism in male and female cynomolgus macaques (Macaca fascicularis). Alcoholism: Clinical and Experimental Research 23, 611-616. (Pubitemid 29203216)
30. Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ (2007). Biochemical markers of alcoholism. Clinical Chemistry and Laboratory Medicine 45, 953-961. (Pubitemid 47424855)
31. Harwood H (2000). Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods, and Data. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.
32. Helander A (2003). Biological markers in alcoholism. Journal of Neural Transmission (Suppl.) 66, 15-32. (Pubitemid 38339941)
33. Helander A, Eriksson CJ (2002). Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcoholism: Clinical and Experimental Research 26, 1070-1077. (Pubitemid 34778784)
34. Hock B, Schwarz M, Domke I, Grunert VP, et al. (2005). Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 100, 1477-1486. (Pubitemid 41442317)
35. Hoyumpa AM (1986). Mechanisms of vitamin deficiencies in alcoholism. Alcoholism: Clinical and Experimental Research 10, 573-581. (Pubitemid 17226975)
36. Ivester P, Roberts LJ, Young T, Stafforini D, et al. (2007). Ethanol self-administration and alterations in the livers of the cynomolgus monkey, Macaca fascicularis. Alcoholism: Clinical and Experimental Research 31, 144-155. (Pubitemid 46025377)
37. Junge J, Bentsen KD, Christoffersen P, Orholm M, et al. (1988). Fibronectin as predictor of cirrhosis in men who abuse alcohol. British Medical Journal (Clinical Research Edition) 296, 1629-1630.
38. Kip MJ, Spies CD, Neumann T, Nachbar Y, et al. (2008). The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting. Alcoholism: Clinical and Experimental Research 32, 1284-1291.
39. Kissack JC, Bishop J, Roper AL (2008). Ethylglucuronide as a biomarker for ethanol detection. Pharmacotherapy 28, 769-781. (Pubitemid 351975380)
40. Koch H, Meerkerk GJ, Zaat JO, Ham MF, et al. (2004). Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review. Alcohol and Alcoholism 39, 75-85. (Pubitemid 38386879)
41. Korzec A, de Bruijn C, van Lambalgen M (2005). The Bayesian alcoholism test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use. Journal of Clinical Epidemiology 58, 1024-1032. (Pubitemid 41316445)
42. Korzec S, Korzec A, Conigrave K, Gisolf J, et al. (2009). Validation of the Bayesian alcoholism test compared to single biomarkers in detecting harmful drinking. Alcohol and Alcoholism 44, 398-402.
43. Lebold KM, Grant KA, Freeman WM, Wiren KM, et al. (2010). Individual differences in hyperlipidemia and vitamin E status in response to chronic alcohol self-administratin in cynomolgous monkeys. Alcoholism: Clinical and Experimental Research. Published online: 30 November 2010. doi:10.1111/j.1530- 0277.2010.01364.x.
44. Niemela O (2007). Biomarkers in alcoholism. Clinica Chimica Acta 377, 39-49. (Pubitemid 44908237)
45. Pernanen K (1974).Validity of survey data on alcohol use. In: Gibbons et al. (Ed.), Research Advances in Alcohol and Drug Problems (pp. 355-374). New York, John Wiley &Sons.
46. Pineiro M, Alava MA, Gonzalez-Ramon N, Osada J, et al. (1999). ITIH4 serum concentration increases during acute-phase processes in human patients and is up-regulated by interleukin-6 in hepatocarcinoma HepG2 cells. Biochemical and Biophysical Research Communications 263, 224-229. (Pubitemid 29443667)
47. Pruett BS, Pruett SB (2006). An explanation for the paradoxical induction and suppression of an acute phase response by ethanol. Alcohol 39, 105-110. (Pubitemid 44667710)
48. Sobell LC, Sobell MB (1992). Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R, Allen J (Eds), Measuring Alcohol Consumption (pp. 41-72). New York: Humana Press.
49. Spitzer RL, Williams JBW (2002). Structured Clinical Interview for the DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
50. Steinweg DL, Worth H (1993). Alcoholism: the keys to the CAGE. American Journal of Medicine 94, 520-523. (Pubitemid 23142968)
51. Taracha E, Habrat B, Wozniak P, Walkowiak J, et al. (2001). The activity of beta-hexosaminidase (uHex) and gamma-glutamyl-transferase (uGGT) in urine as non-invasive markers of chronic alcohol abuse: I. Alcohol-dependent subjects. World Journal of Biological Psychiatry 2, 184-189.
52. Umstead TM, Lu CJ, Freeman WM, Myers JL, et al. (2010). Dual-platform proteomics study of plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass. Pediatric Research 67, 641-649.
53. VanGuilder HD, Bixler GV, Kutzler L, Brucklacher RM, et al. (2011). Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. PLoS ONE 6, e16271.
54. VanGuilder HD, Yan H, Farley JA, Sonntag WE, et al. (2010). Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome. Journal of Neurochemistry 113, 1577-1588.
55. Vendemiale G, Grattagliano I, Altomare E, Serviddio G, et al. (2001). Mitochondrial oxidative damage and myocardial fibrosis in rats chronically intoxicated with moderate doses of ethanol. Toxicology Letters 123, 209-216. (Pubitemid 32971726)
56. Vivian JA, Green HL, Young JE, Majerksy LS, et al. (2001). Induction and maintenance of ethanol self-administration in cynomolgus monkeys (Macaca fascicularis): long-term characterization of sex and individual differences. Alcoholism: Clinical and Experimental Research 25, 1087-1097. (Pubitemid 32758459)
57. Yang Q, Graham TE, Mody N, Preitner F, et al. (2005). Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356-362. (Pubitemid 41065039)
58. Zolotarjova N, Mrozinski P, Chen H, Martosella J (2008). Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. Journal of Chromatography A 1189, 332-338.